General Information of Drug Transporter (DT)
DT ID DTD0339 Transporter Info
Gene Name SLC39A11
Transporter Name Zinc transporter ZIP11
Gene ID
201266
UniProt ID
Q8N1S5
Post-Translational Modification of This DT
Overview of SLC39A11 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          8 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A11 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

125

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 125 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC39A11 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

137

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 137 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC39A11 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

140

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 140 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC39A11 [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

153

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 153 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC39A11 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

179

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 179 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC39A11 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

224

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 224 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC39A11 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

229

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 229 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC39A11 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

249

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC39A11 Serine 249 has the potential to affect its expression or activity.

Ubiquitination

  Alanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A11 [8]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

113

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Alanine 113 has the potential to affect its expression or activity.

  Glycine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A11 [9]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

72

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Glycine 72 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC39A11 [9]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

74

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Glycine 74 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC39A11 [8]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

156

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Glycine 156 has the potential to affect its expression or activity.

  Lysine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A11 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

122

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Lysine 122 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC39A11 [9]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

123

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Lysine 123 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC39A11 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

124

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Lysine 124 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC39A11 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

152

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Lysine 152 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC39A11 [10]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

163

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Lysine 163 has the potential to affect its expression or activity.

  Phenylalanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC39A11 [9]

Role of PTM

Potential impacts

Modified Residue

Phenylalanine

Modified Location

73

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC39A11 Phenylalanine 73 has the potential to affect its expression or activity.
References
1 Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
2 Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
3 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
4 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
5 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
6 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7 Kinase-substrate enrichment analysis provides insights into the heterogeneity of signaling pathway activation in leukemia cells. Sci Signal. 2013 Mar 26;6(268):rs6.
8 Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
9 Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
10 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.